Finding medicines for people with limited or no options.

Investors

Email Alerts

Sign up to receive e-mail alerts whenever Jazz Pharmaceuticals posts new information to the site.

Sign up for RSS feeds

Investor Contacts

Andrea N. Flynn, Ph.D. 
Vice President, Head,
Investor Relations

investorinfo@jazzpharma.com
Ireland: +353 1 634 7892
U.S.: +1 650 496 2800

Investors

Corporate Overview

Jazz Pharmaceuticals plc (Nasdaq: JAZZ), a global biopharmaceutical company, is dedicated to developing life-changing medicines for people with limited or no options. Our strategy is to create shareholder value by:

  • Growing sales of the existing products in our portfolio, including by identifying new growth opportunities;
  • Acquiring additional differentiated products that are on the market or product candidates that are in late-stage development; and
  • Pursuing focused development of a pipeline of post-discovery differentiated product candidates.

We have made substantial progress in the execution of our strategy. We have a diverse portfolio of products and product candidates, with a focus in the areas of sleep and hematology/oncology.